Join integrative physician Dr. Dian Ginsberg for a clinical discussion on how epigenetics, methylation, and insulin resistance influence inflammation, metabolic dysfunction, and patient outcomes. This session bridges emerging research with practical strategies for providers focused on achieving metabolic balance across diverse patient populations. What You’ll Learn: ✅ How epigenetic changes impact inflammatory and insulin-resistant states ✅ The role of methylation in metabolic balance and chronic disease progression ✅ Key biomarkers and protocols for identifying upstream dysfunction ✅ Clinical strategies for applying these insights